
CYP17A1 inhibitor abiraterone, an anti-prostate cancer drug, also inhibits the 21-hydroxylase activity of CYP21A2
Keywords: Abiraterone; CYP21A2; CYP17A1; Prostate cancer; Cytochrome P450; Steroidogenesis; Androgens;